Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base

EuroIntervention 2012;7:1103-1110 publish online ahead of print September 2011. DOI: 10.4244/EIJV7I9A175

Annette Maznyczka1*, BSc, MBChB; Aung Myat2, BSc, MBBS, MRCP; Anthony Gershlick1, BSc, MBBS, FRCP

1. Department of Cardiology, Glenfield Hospital, Leicester, United Kingdom; 2. The Rayne Institute, St Thomas’ Hospital, King’s College London, London, United Kingdom

Aims: Metformin is widely prescribed for the treatment of type 2 diabetes mellitus and is associated with a reduction in diabetes-induced cardiovascular morbidi

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

metforminlactic acidosiscoronary angiographyguidelines

Share on Facebook Share on Twitter Share on Linkedin

Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base

Read next article

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke